Clinical Trials Browser

Kidney Neoplasms × Sorafenib × Dermatologic × Clear all

NCT00418496 2017-02-20

Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma

Phase 1 Completed

DermatologicGenitourinary

Kidney Neoplasms, Melanoma, Neoplasm Metastasis